CIM Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $589K | Buy |
29,573
+14,841
| +101% | +$296K | 0.11% | 162 |
|
|
2025
Q1 | $245K | Sell |
14,732
-350
| -2% | -$5.81K | 0.06% | 199 |
|
|
2024
Q4 | $277K | Hold |
15,082
| – | – | 0.08% | 195 |
|
|
2024
Q3 | $232K | Hold |
15,082
| – | – | 0.07% | 211 |
|
|
2024
Q2 | $245K | Sell |
15,082
-3,588
| -19% | -$58.3K | 0.08% | 203 |
|
|
2024
Q1 | $345K | Buy |
18,670
+8,418
| +82% | +$156K | 0.1% | 188 |
|
|
2023
Q4 | $321K | Hold |
10,252
| – | – | 0.1% | 184 |
|
|
2023
Q3 | $214K | Hold |
10,252
| – | – | 0.08% | 238 |
|
|
2023
Q2 | $246K | Buy |
+10,252
| New | +$246K | 0.08% | 222 |
|
|
2018
Q4 | – | Sell |
-13,593
| Closed | -$282K | – | 297 |
|
|
2018
Q3 | $282K | Sell |
13,593
-1,279
| -9% | -$26.5K | 0.1% | 281 |
|
|
2018
Q2 | $227K | Buy |
+14,872
| New | +$227K | 0.08% | 317 |
|
|
2017
Q3 | – | Sell |
-8,807
| Closed | -$246K | – | 316 |
|
|
2017
Q2 | $246K | Sell |
8,807
-276
| -3% | -$7.71K | 0.09% | 317 |
|
|
2017
Q1 | $312K | Hold |
9,083
| – | – | 0.11% | 256 |
|
|
2016
Q4 | $262K | Hold |
9,083
| – | – | 0.1% | 287 |
|
|
2016
Q3 | $289K | Buy |
9,083
+350
| +4% | +$11.1K | 0.11% | 252 |
|
|
2016
Q2 | $283K | Buy |
+8,733
| New | +$283K | 0.12% | 226 |
|
|
2015
Q1 | – | Sell |
-6,340
| Closed | -$201K | – | 258 |
|
|
2014
Q4 | $201K | Buy |
+6,340
| New | +$201K | 0.09% | 237 |
|